companydata.dkcompanydata.dk
Back to company

LEO PHARMA A/S: Financial statements 2013

CVR: 56759514

LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 5,782,000,000 and a net result of DKK 1,175,000,000. The profit margin was 20.3%. Equity amounted to DKK 23,136,000,000. The solvency ratio was 70.1%. The company had 4,733 employees in the financial year.

Revenue
5,782,000,000 kr.
Profit/Loss
1,175,000,000 kr.
Equity
23,136,000,000 kr.
Total Assets
33,004,000,000 kr.
Employees
4,733

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like LEO PHARMA A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2013

LEO PHARMA A/S: The 2012 annual report is outMar 24, 2013

LEO PHARMA A/S has published its annual report for 2012.

About LEO PHARMA A/S

LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Philip Harald Eickhoff and Christophe Dominique Luc Charles Bourdon. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 2,040 employees. In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity amounted to DKK 5,262,000,000.

Other financial years

202520242023202220212020201920182017201620152014